ArticleBMC pediatrics2025
Spatial distribution and associated factors of zero-dose immunization among 12-23 month-old children in Ethiopia: spatial and survey regression analysis.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Spatial distribution and multilevel analysis of full vaccination coverage among children aged 12-23 months in Democratic Republic of Congo.Global epidemiology · 2026Article
- Enhancing the use of routine program data for immunization decision-making: The role of coincidence analysis in localized learning and adaptation.Human vaccines & immunotherapeutics · 2025Article
- Multilevel Analysis of Zero-Dose Children in Sub-Saharan Africa: A Three Delays Model Study.Vaccines · 2025Article
- Zero-Dose Vaccination Among Children Aged 12-35 Months in Ethiopia.TheScientificWorldJournal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundImmunization is one of the public health interventions, saving millions of lives. Despite this, many children, especially those living in low- and middle-income countries, continue to miss out on lifesaving vaccines, the worst of which is zero-dosage. It is crucial to identify individuals and obtain timely, reliable information on their geographic distribution and related attributes to support spatially tailored strategies and interventions. Undoubtedly, assessing zero-dose prevalence is an input to achieve the WHO's 2030 agenda, which attempts to reduce the number of zero-dose children. Hence, this study aimed to determine the prevalence, spatial distribution and associated factors of zero-dose immunization among children in Ethiopia.
methodsA secondary analysis of the Ethiopian mini demographic and health survey 2019 data was conducted. Our analysis focused on zero-dose immunization among children aged 12-23 months. Geographic variations in zero-dose prevalence were assessed using spatial analysis techniques, including Moran's I statistic and inverse distance weighted interpolation. Bivariable and multivariable survey logistic regression models were used to identify factors associated with zero-dose immunization.
resultsA total of 1008 children aged 12 to 23 months old were retained for the final analysis. The overall weighted prevalence of zero-dose immunization status at national level in Ethiopia was 23.7% [95% CI: 18.7-28.5]. Hot spots of zero-dose immunization were observed in southwest and northeast part of Ethiopia whereas cold spots of zero-dose immunization were observed in the central and northern parts of the country. Rural resident children [AOR = 2.55; 95%CI: 1.05, 6.22], female children (AOR = 1.78; 95%CI: 1.09, 2.91), children not delivered at the health institution (AOR = 4.12; 95% CI: 2.39, 7.08), and children from a mother did not completed four or more ANC visits (AOR = 2.55; 95% CI: 1.37, 4.75) were more likely to be zero-dose as compared to their counter parts.
conclusionThere is high prevalence of children being zero-dose among 12-23 months old children in Ethiopia. Interventions tailored on geographic areas, residence, sex of the child, four or more ANC visits and institutional delivery could help to reduce zero-dose children in Ethiopia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.